MFS
CDTX

MSI Financial Services’s Cidara Therapeutics CDTX Stock Holding History

MSI Financial Services’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-6
Closed -$2K – 3961
2015
Q4 		$2K Buy
+6
New +$1.8K ﹤0.01% 3412

Other funds holding CDTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

MSI Financial Services's CDTX Position: Q1 2016 in Review

MSI Financial Services sold out of Cidara Therapeutics (CDTX) in Q1 2016, closing a stake of 6 shares — an estimated $2K sold.

MSI Financial Services first reported a position in CDTX in Q4 2015 and held it in 1 quarter. The position peaked at $2K in Q4 2015. 46 funds tracked by Wall St. Rank hold CDTX as of Q1 2016.

  • MSI Financial Services reported no remaining Cidara Therapeutics position as of Q1 2016 after selling out during the quarter.
  • MSI Financial Services sold 6 Cidara Therapeutics shares in Q1 2016, an estimated $2K.
  • MSI Financial Services first reported a position in Cidara Therapeutics in Q4 2015 and held it in 1 quarter.
  • MSI Financial Services's Cidara Therapeutics position peaked at $2K in Q4 2015.
  • 46 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2016.

Based on MSI Financial Services's 13F filing for Q1 2016, filed 22 Apr 2016.